Skip to main navigation COVID-19 UPDATE Contact BDSI remains committed to the chronic pain community during the COVID-19 pandemic. For more information on access to our products, please call our customer service line at 1-800-469-0261. Investors Investor Resources INVESTOR RESOURCES Investor Relations BioDelivery Science International, Inc. 919-582-0294 Name Email Subject Comments Site - Shareholder Tools Print Page RSS Feeds Email Alerts Investor Presentation More information is coming soon. Recent BDSI News BioDelivery Sciences Reports Solid Third Quarter 2021 Results November 3, 2021 Total Net Revenue of $41.1 Million , an Increase of 4% versus Prior Year Strong profitability with GAAP EPS of $0.07 , EBITDA Margin of 27% and $7.0 million Operating Cash Flow Closed acquisition of ELYXYB, the first FDA-approved, ready-to-use oral solution for acute migraine with potential ... Read more BioDelivery Sciences Appoints John Golubieski as Chief Financial Officer October 21, 2021 RALEIGH, N.C. , Oct. 21, 2021 (GLOBE NEWSWIRE) -- BioDelivery Sciences International , Inc. (NASDAQ: BDSI), a rapidly growing commercial-stage specialty pharmaceutical company dedicated to patients living with chronic conditions, today announced the appointment of John Golubieski as Chief Financial ... Read more BioDelivery Sciences to Report Third Quarter 2021 Financial Results on November 3, 2021 October 20, 2021 RALEIGH, N.C. , Oct. 20, 2021 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a growing specialty pharmaceutical company dedicated to patients living with chronic conditions, announced today that it will report its third quarter 2021 financial results before the open of ... Read more More news Upcoming Events More events are coming soon. More events Stay Connected Stay up to date on the latest news Get started now November 24, 2021 BDSI $3.00 / -0.96% Data provided by West LLC. Minimum 15 minutes delayed. Site - Main Navigation Company Products Science & Education Investors Careers Copyright © 2021 | BioDelivery Sciences International, Inc. Site - Copyright Menu Terms & Conditions | Privacy Policy